You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Economic evaluation of rivaroxaban in stroke prevention for patients with atrial fibrillation in Greece
|
---|---|
Published in |
Cost Effectiveness and Resource Allocation, February 2014
|
DOI | 10.1186/1478-7547-12-5 |
Pubmed ID | |
Authors |
Georgia Kourlaba, Nikos Maniadakis, George Andrikopoulos, Panos Vardas |
Abstract |
To undertake an economic evaluation of rivaroxaban relative to the standard of care for stroke prevention in patients with non-valvular atrial fibrillation (AF) in Greece. |
X Demographics
The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Greece | 1 | 17% |
Unknown | 5 | 83% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 6 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 55 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Slovenia | 1 | 2% |
Unknown | 54 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 14 | 25% |
Researcher | 11 | 20% |
Student > Bachelor | 5 | 9% |
Student > Ph. D. Student | 5 | 9% |
Student > Doctoral Student | 3 | 5% |
Other | 5 | 9% |
Unknown | 12 | 22% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 38% |
Economics, Econometrics and Finance | 8 | 15% |
Pharmacology, Toxicology and Pharmaceutical Science | 5 | 9% |
Neuroscience | 2 | 4% |
Mathematics | 2 | 4% |
Other | 4 | 7% |
Unknown | 13 | 24% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 April 2021.
All research outputs
#5,405,755
of 25,374,917 outputs
Outputs from Cost Effectiveness and Resource Allocation
#190
of 533 outputs
Outputs of similar age
#62,158
of 327,781 outputs
Outputs of similar age from Cost Effectiveness and Resource Allocation
#5
of 8 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 533 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.9. This one has gotten more attention than average, scoring higher than 64% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,781 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.